{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:16:53Z","timestamp":1788553013969,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtct.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:04:59Z","timestamp":1778051099000},"page":"1125.e1-1125.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Excellent Long-Term Survival and Immune Recovery With Reduced-Intensity Conditioning HCT in Inborn Errors of Immunity"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-5996","authenticated-orcid":false,"given":"Hannah","family":"Lust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-3918","authenticated-orcid":false,"given":"Olatundun","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schneiderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggie","family":"Duerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-3270","authenticated-orcid":false,"given":"David","family":"Jacobsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6950-7648","authenticated-orcid":false,"given":"Angelo","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8477-9239","authenticated-orcid":false,"given":"Ramsay","family":"Fuleihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Kletzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.05.002_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.jtct.2026.05.002_bib0002","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbmt.2019.03.008","article-title":"Low exposure busulfan conditioning to achieve sufficient multilineage chimerism in patients with severe combined immunodeficiency","volume":"25","author":"Dvorak","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.05.002_bib0003","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.05.002_bib0004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11882-019-0883-1","article-title":"Conditioning regimens for hematopoietic cell transplantation in primary immunodeficiency","volume":"19","author":"Lum","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.002_bib0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbmt.2017.11.009","article-title":"Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience","volume":"24","author":"Slatter","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.002_bib0006","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","article-title":"Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience","volume":"128","author":"Morillo-Gutierrez","year":"2016","journal-title":"Blood"},{"issue":"9429","key":"10.1016\/j.jtct.2026.05.002_bib0007","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(04)16628-2","article-title":"Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children","volume":"364","author":"Jacobsohn","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.002_bib0008","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2015.277","article-title":"Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center study","volume":"51","author":"Hamidieh","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.002_bib0009","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jaci.2018.12.1010","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT\/ESID-IEWP-SCETIDE-PIDTC study","volume":"143","author":"Ferrua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"23","key":"10.1016\/j.jtct.2026.05.002_bib0010","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/blood.2019002939","article-title":"Excellent outcomes following hematopoietic cell transplantation for Wiskott\u2013Aldrich syndrome: a PIDTC report","volume":"135","author":"Burroughs","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.002_bib0011","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/bloodadvances.2025016812","article-title":"Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: A report from the PIDTC","volume":"10","author":"Rayes","year":"2026","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2026.05.002_bib0012","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.bbmt.2014.06.003","article-title":"Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency\/X-linked lymphoproliferative disease type 1","volume":"20","author":"Marsh","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.05.002_bib0013","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.bbmt.2015.05.017","article-title":"Single daily busulfan dosing for infants with nonmalignant diseases undergoing reduced-intensity conditioning for allogeneic hematopoietic progenitor cell transplantation","volume":"21","author":"Ward","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.05.002_bib0014","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","article-title":"The diagnosis of severe combined immunodeficiency (SCID): the primary immune deficiency treatment consortium (PIDTC) 2022 definitions","volume":"151","author":"Dvorak","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jtct.2026.05.002_bib0016","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.002_bib0017","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.jtct.2026.05.002_bib0018","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.05.002_bib0019","first-page":"275","article-title":"Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders","author":"Slavin","year":"2003","journal-title":"Clin Transpl"},{"issue":"3","key":"10.1016\/j.jtct.2026.05.002_bib0020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.002_bib0021","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.jaci.2021.10.017","article-title":"Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort","volume":"149","author":"Lankester","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"25","key":"10.1016\/j.jtct.2026.05.002_bib0022","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.002_bib0023","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ACI.0000000000000115","article-title":"Stem cell transplantation for primary immunodeficiency diseases: the North American experience","volume":"14","author":"Pai","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.002_bib0024","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s10875-021-00966-z","article-title":"Hematopoietic cell transplantation with reduced intensity conditioning using fludarabine\/busulfan or fludarabine\/melphalan for primary immunodeficiency diseases","volume":"41","author":"Nishimura","year":"2021","journal-title":"J Clin Immunol"},{"issue":"9","key":"10.1016\/j.jtct.2026.05.002_bib0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcyt.2023.05.012","article-title":"Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis","volume":"25","author":"Troullioud Lucas","year":"2023","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jtct.2026.05.002_bib0026","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jaci.2016.12.992","article-title":"Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation","volume":"140","author":"Admiraal","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.jtct.2026.05.002_bib0027","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcyt.2020.05.005","article-title":"Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"van Roessel","year":"2020","journal-title":"Cytotherapy"},{"issue":"17","key":"10.1016\/j.jtct.2026.05.002_bib0028","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2026.05.002_bib0029","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fped.2019.00552","article-title":"Hematopoietic stem cell transplantation for combined immunodeficiencies, on behalf of IEWP-EBMT","volume":"7","author":"Neven","year":"2019","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.jtct.2026.05.002_bib0030","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jaci.2018.06.042","article-title":"One hundred percent survival after transplantation of 34 patients with Wiskott\u2013Aldrich syndrome over 20 years","volume":"142","author":"Elfeky","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2026.05.002_bib0031","article-title":"Hematopoietic cell transplantation for Wiskott\u2013Aldrich syndrome: a PIDTC report","author":"Alexander","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.05.002_bib0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2023.09.027","article-title":"Posttransplantation late complications increase over time for patients with SCID: a primary immune deficiency treatment consortium (PIDTC) landmark study","volume":"153","author":"Eissa","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"10.1016\/j.jtct.2026.05.002_bib0033","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1182\/blood-2008-09-177923","article-title":"Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency","volume":"113","author":"Neven","year":"2009","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600343X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600343X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:00:42Z","timestamp":1788552042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600343X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S266663672600343X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.002","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excellent Long-Term Survival and Immune Recovery With Reduced-Intensity Conditioning HCT in Inborn Errors of Immunity","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}